![Sireesh Appajosyula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 265 982 $ in data 30/06/2026
Sireesh Appajosyula currently works at Hepion Pharmaceuticals, Inc., as Director from 2026, Highpoint Pharmaceuticals LLC, as Managing Member from 2018, and Channel Bioconsulting LLC, as Managing Partner from 2015.
Dr. Appajosyula also formerly worked at Canton Strategic Holdings, Inc., as Chief Financial Officer in 2025, 9 Meters Biopharma, Inc., as SVP-Corporate Development & Operations, and Salix Pharmaceuticals, Inc., as Head-Business Development.
Dr. Appajosyula received his undergraduate degree from Rutgers State University of New Jersey and doctorate degree from Ernest Mario School of Pharmacy.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/06/2026 | 64.178 ( 0,08% ) | 180 982 $ | 30/06/2026 | |
| 28/04/2026 | 1.250.000 ( 4,29% ) | 85 000 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 16/03/2026 |
Highpoint Pharmaceuticals LLC | Corporate Officer/Principal | 01/01/2018 |
Channel Bioconsulting LLC | Corporate Officer/Principal | 01/01/2015 |
| Società | Posizione | Fine |
|---|---|---|
| CANTON STRATEGIC HOLDINGS, INC. | Amministratore Delegato | - |
| 9 METERS BIOPHARMA, INC. | Direttore operativo | 17/07/2023 |
Salix Pharmaceuticals, Inc.
 Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernest Mario School of Pharmacy
 Ernest Mario School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Tharimmune, Inc.
 Tharimmune, Inc. Data Processing ServicesTechnology Services Engages in institutional blockchain infrastructure and digital asset treasury management and clinical stage bio-technology services | Technology Services |
Highpoint Pharmaceuticals LLC | |
Channel Bioconsulting LLC |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
